We are on Bluesky now! Come find us → @icmlugano.bsky.social
⏳ Last week for 18-ICML abstract submission! (deadline 15 March at 17:59 CET).
📊 Late-breaking abstracts: covering letters due by 15 March at 17:59 CET.
👉icml.ch/icml/congresses/18-i…
#lymphoma #lymsm #CLL #myeloma
📢 📄 The abstract submission for the #18ICML is officially OPEN! Abstracts can be related to all aspects of the biology and treatment of #lymphoidneoplasms, including #CLL and #multiplemyeloma. More info: bit.ly/3ZBwOU3 #lymsm #lymphoma #myeloma
📢Registration for the 2025 Lymphoma Forum of Excellence is open!
Join this annual meeting in Bellinzona, Switzerland.
Designed by lymphoma experts, the program offers updated knowledge and multidisciplinary case discussions.
🔗Info and registration: lymphomaforum.ch
📢Registration to the 18-ICML is open!
Don't miss the opportunity to participate in the only international conference that focuses exclusively on #lymphoidneoplasms!
🔗Register now: shorturl.at/LHtyT
International Conference on Malignant Lymphoma retweeted
Deadline Extended:
Submit an abstract by April 19 for the Fourth AACR International Meeting on Advances in Malignant Lymphoma (June 19-22, Philadelphia), chaired by Michael R. Green and organized in association with @BCD_AACR.
bit.ly/3vxlOfk
#AACRlymph24 @GreenLymphoLab
International Conference on Malignant Lymphoma retweeted
#IORnews
We are honored to announce that the IOR Foundation President, Prof. Franco Cavalli, will receive the "Award for Lifetime Achievement" from the @AACR in recognition of his outstanding contributions to oncology.
🔗Read the news: usi.ch/en/feeds/27552
International Conference on Malignant Lymphoma retweeted
#IORnews
The Lymphoma Genomics Lab, guided by Prof. Bertoni @frbertoni identified a new mechanism behind the resistance to BTK and PI3K inhibitors used in the treatment of follicular lymphoma, mantle cell lymphoma and marginal zone lymphoma.
🔗The news: shorturl.at/ouwJ8
Thank you for attending the #17ICML!
A huge "thank you" also to our Advisory Board, Reviewers, Faculty, cooperating Scientific Societies @AACR @ESOncology @myESMO and Sponsors for their precious support.
See you in 2025!
International Conference on Malignant Lymphoma retweeted
🔍💼 CALL FOR NEW GROUP LEADER AT THE IOR
The IOR is looking for a Group Leader in Lymphoma Biology and Therapy.
More information: bit.ly/3WaG8fk
📖 The #17ICML Abstract and Educational Books, supplements to "Hematological Oncology" (John Wiley and Sons, Inc.), are online!
🔗 Abstract Book: shorturl.at/qF145
🔗 Educational Book: t.ly/8NZm
🎤#17-ICML Late Breaking Abstracts Session
The content of the #17ICML Late Breaking Abstracts Session (Saturday, June 17, 10:15 - 11:30) is now online!
👉🏻 Discover the presentations here: shorturl.at/lvF38
🏃🏻Join the «Corsa della speranza (Run for Hope)», a charity run organized in collaboration with «La Corsa della speranza» during the 17-ICML with the aim to collect funds for cancer research projects carried out in Southern Switzerland.
🔗bit.ly/41xm7S9
🎤#17ICML Plenary session
"Nivolumab(N)-AVD Improves Progression-Free Survival Compared to Brentuximab Vedotin(BV)-AVD in Advanced Stage (AS) Classic Hodgkin Lymphoma (HL): Results of SWOG S1826" A. F. Herrera (Duarte, CA, US
🔗Complete Scientific Program: bit.ly/3IlOc7h
🎤#17ICML Plenary session
"Frontline intensified ABVD demonstrates superior efficacy than PET-adapted ABVD in advanced HL: the FIL-Rouge Phase 3 Trial by the Fondazione Italiana Linfomi" A. Pinto (Naples, IT)
👉🏻Check out the complete Scientific Program: bit.ly/3IlOc7h